PMID- 24323863 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20131211 LR - 20211021 IS - 1868-601X (Electronic) IS - 1868-4483 (Print) IS - 1868-4483 (Linking) VI - 3 IP - Suppl 1 DP - 2012 Jul TI - Chemokines and their receptors in intracerebral hemorrhage. PG - 70-9 LID - 10.1007/s12975-012-0155-z [doi] AB - Intracerebral hemorrhage (ICH) is a devastating clinical event which results in a high rate of disability and death. At present, no effective treatment is available for ICH. Accumulating evidence suggests that inflammatory responses contribute significantly to the ICH-induced secondary brain outcomes. During ICH, inflammatory cells accumulate at the ICH site attracted by gradients of chemokines. This review summarizes recent progress in ICH studies and the chemoattractants that act during the injury and focuses on and introduces the basic biology of the chemokine monocyte chemoattractant protein-1 (MCP1) and its role in the progression of ICH. Better understanding of MCP1 signaling cascade and the compensation after its inhibition could shed light on the development of effective treatments for ICH. FAU - Yao, Yao AU - Yao Y AD - Program in Molecular and Cellular Pharmacology, Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, 11794-8651, USA. FAU - Tsirka, Stella E AU - Tsirka SE LA - eng GR - R01 NS042168/NS/NINDS NIH HHS/United States PT - Journal Article DEP - 20120403 PL - United States TA - Transl Stroke Res JT - Translational stroke research JID - 101517297 PMC - PMC7453158 MID - NIHMS1559957 EDAT- 2012/07/01 00:00 MHDA- 2012/07/01 00:01 PMCR- 2020/08/28 CRDT- 2013/12/11 06:00 PHST- 2012/02/28 00:00 [received] PHST- 2012/03/13 00:00 [accepted] PHST- 2012/03/12 00:00 [revised] PHST- 2013/12/11 06:00 [entrez] PHST- 2012/07/01 00:00 [pubmed] PHST- 2012/07/01 00:01 [medline] PHST- 2020/08/28 00:00 [pmc-release] AID - 10.1007/s12975-012-0155-z [doi] PST - ppublish SO - Transl Stroke Res. 2012 Jul;3(Suppl 1):70-9. doi: 10.1007/s12975-012-0155-z. Epub 2012 Apr 3.